Annual Drug Patent Expirations for OPSUMIT
Opsumit is a drug marketed by Actelion and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for OPSUMIT.
This drug has eigthy-four patent family members in thirty-two countries.
The generic ingredient in OPSUMIT is macitentan. One supplier is listed for this compound. Additional details are available on the macitentan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
